학술논문
Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
Document Type
article
Author
Source
EBioMedicine, Vol 79, Iss , Pp 103993- (2022)
Subject
Language
English
ISSN
2352-3964
Abstract
Summary: The Mycobacterium bovis BCG vaccine was first used in 1921, but has not controlled the global spread of tuberculosis (TB). There are still no new licensed tuberculosis vaccines, although there much active research and a vaccine development pipeline, with vaccines designed to prevent infection, prevent disease, or accelerate TB treatment. These vaccines are of different types, and designed to replace BCG, or to boost immunity following BCG vaccination. This viewpoint discusses why, when it has been possible to develop new vaccines for SARS-CoV-2 so quickly, it is taking so long to develop new tuberculosis vaccines.